CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Details

Daily high

$5.77

Daily low

$5.30

Price at open

52 Week High

$13.88

52 Week Low

$4.45

Market cap

835.4M

Dividend yield

0.00%

Volume

5.2M

Avg. volume

4.3M

P/E ratio

-56.35

Certara News